New From Bentham Science: ‘Coronaviruses’

Bentham Science is happy to announce an important new journal, Coronaviruses. It will focus specifically on the latest research on the various coronavirus strains, recent COVID-19 outbreak, and the emerging methods employed to treat coronavirus infections and prevent future outbreaks.

During these difficult times, it is more important than ever to support the scientists working around the clock to understand, treat, and prevent coronavirus outbreaks. Every day, new discoveries are made in different corners of the world. Virologists, epidemiologists, microbiologists, immunologists, doctors, and many other scientists and medical professionals are still learning about this virus. They are trying to determine just how the coronavirus spreads, how it mutates between different hosts, and what symptoms it causes. These scientists are also working to discover effective treatments and to potentially develop a vaccine that could help prevent a future outbreak.

Bentham Science knows that having access to cutting-edge, up-to-date information on coronavirus is essential to people around the world. Scientific research is informing government policies and responses to the outbreak around the world, and it is important to make those decisions with the most accurate information available. With that in mind, every article in the first issue of the journal will be published as open access, meaning it will be free to download for the first three months after its publication.

Coronaviruses will publish original research articles, letters, reviews/mini-reviews, and guest-edited thematic issues on all aspects of coronaviruses, including (but not limited to) their origins, types, transmission, pathogenesis, epidemiological, demographic, clinical, and genomic characteristics. The journal will also cover case reports and studies on outbreak of coronaviruses, their symptoms, related diseases, prevention, treatment regimens, and development of new drugs.

We are proud to name Dr. Di Liu as the Editor-in-Chief of the new Coronaviruses journal. Dr. Di Liu is a Principal Investigator at the Wuhan Institute of Virology, a world-renowned institution on virus research doing work at the heart of the current outbreak. His research focuses are microbial genomic and meta-genomic analyses and bioinformatics analyses on pathogenic microbes.

The Honorary Editors of the journal are Dr. Ferid Murad, a Nobel prize winning physician and pharmacologist, and Professor Atta-Ur-Rahman, FRS, an award-winning chemist from Karachi University.

This new journal will be essential reading for virologists, epidemiologists, microbiologists, healthcare workers, and scientists of all kinds interested in the latest information about coronaviridae.

For more information about Bentham Science, please visit their website.

can also connect with Bentham Science on FacebookTwitter, and LinkedIn.

China honors our Eminent Scientist Prof. Atta ur Rahman with Science and Technology Cooperation Award

 

bentham-news-post

 

BEIJING, Jan 10 (APP):Renowned Pakistani scientist Prof. Dr. Atta-ur-Rahman has been conferred the highest scientific award of China in a ceremony held at the Great Hall of the People here on Friday.

Chinese President Xi Jinping and senior Chinese government officials attended the ceremony. Pakistan Ambassador to China, Nahgmana Alamgir Hashmi was also present on the occasion, according to an official statement issued here.

The International Scientific and Technological Cooperation Award is the most prestigious national science and technology award of China. It is granted to foreign scientists, engineers or organizations that have made important contributions to China’s bilateral or multilateral scientific and technological cooperation.

The ‘China International Science and Technology Cooperation Award’, for the year 2020 has been awarded to Prof. Dr. Atta-ur-Rahman in recognition of his significant contributions in the field of Chemistry.

This top international award has previously been given to several leading scientists of the world including the Nobel Laureates, Dr. Carlo Rubbia (Nobel Prize in physics, 1984) and Dr. Zhores I. Alferov (Nobel Prize in physics, 2000).

It is pertinent to mention here that China and Malaysia have also established major research Centers in his name in recognition of his international eminence.

Currently, Prof. Atta-ur-Rahman is serving as Chairman of Prime Minister’s Task Force on Science and Technology, Vice Chairman on Prime Minister’s Task Force on Technology-Driven Knowledge-Economy, and Co-Chairman, Task Force on Information Technology.

However, he has also served the nation as a federal minister for science and technology, and chairman higher education commission.

Prof. Atta-ur-Rahman is the most decorated scientist of Pakistan having won four civil awards including Tamgha-i-Imtiaz, Sitara-i-Imtiaz, Hilal-i-Imtiaz and the highest national award Nishan-i-Imtiaz.

He obtained his Ph.D. in organic chemistry from Cambridge University (1968). He has 1250 publications in several fields of organic chemistry including 775 research publications, 45 international patents, 69 chapters in books and 341 books published largely by major U.S. and European presses. Atta ur RehmanHe is the Editor-in-Chief of eight European Chemistry journals and is editor of the world’s leading encyclopedic series of volumes on natural products “Studies in Natural Product Chemistry” 62 volumes of which have been published under his editorship? during the last two decades.

 

As many as 82 students have completed their Ph.D. degrees under his supervision. He has also been awarded various national and international awards in recognition of his outstanding contributions to the field of science and technology. To read the full new of our Eminent Scientist Dr. Atta-ur Rahman Please visit: https://bit.ly/2PW3C7a

CNPIEC awarded Bentham Science Publishers “Partner of Excellence”

Partner of excellence.jpg

In consideration of our intimate/growing cooperation, CNPIEC awarded us “Partner of Excellence” on their 70th Birthday

China National Publications Import and Export (Group) Corporation is the largest publications import and export company and international book fair organizer in China and is specialized in trading books, periodicals and audio & video products in China.

Bentham Science Publishers is rendering a vital service in the quality publication that publishes over 100 peer-reviewed print and online scientific and medical journals.

Press Release for EurekAlert! Non-ambient conditions in the investigation and manufacturing of drug forms

Before it reaches the store shelf, a drug molecule must be prepared in a very specific way. The nature of this prepared form is of the utmost importance, as it must be robust through manufacture, packaging, transport and storage. Ultimately, this prepared drug form must have the necessary physical properties to ensure that the correct amount of drug is available to the consumer. For the successful preparation of this drug form, one often needs to produce solid samples with a controlled crystal structure and specific particle size and shape. To complicate matters, these drug crystals are often required as a part of multi-component composites. The present review summarizes how extreme pressure and temperature conditions help to achieve this goal.

cecea6487bb6533f924c57e4a5dfdfd373bb10e3aaa475caebpimgpsh_fullsize_distr

To become a drug, a pharmacologically active compound must be prepared in a specific form. This form must be robust during manufacturing, packaging, storage and transport, and must administer the correct dose to the patient. To successfully prepare a drug form, one often needs to produce solid samples with controlled crystal structure and a specific particle size and shape. To further complicate matters, these compounds, these drug particles must often end up as a part of a multi-component composite. The present review summarizes how extreme pressure and temperature conditions help achieve this highly tuned material.

In modern culture, it is very rare to find an individual who has never taken any form of medication. It must follow that the pharmaceutical industry is required to produce an enormous quantity of drug products, which can take  a variety of different forms: solutions for injections, inhalation powders, sprays, tablets, ointments, patches, amongst others. In many cases, although adopting different administration routes, different trade names are used to market the very same active pharmaceutical ingredient (API). This begs the question: if these products are the same API, is there any difference in which form is taken?

Quite simply put, yes.

Drug molecules move around the body and, by necessity, act at the molecular level. However, many of these compounds are manufactured as solids, which must either be dissolved prior to injection, or are expected to dissolve on digestion in biological fluids. In either case, dissolution is required to release individual molecules into the body.

Solid pharmaceuticals containing the same API (either pure or with additives) can have different crystal structures (polymorphism) or be amorphous. Additionally, solid particles can differ in size, shape, meso-structure, and surface charge. Within the bulk material, the spatial distribution of an API and the additives can vary. Control of these, and many other, characteristics is within the scope of materials sciences and solid-state chemistry. The chemical and material properties of their physical form therefore needs to be identified and optimized for in vivo performance, reliable manufacture and the protection of intellectual property. 

Drugs are materials, not simply molecules [1-12], By viewing drugs in this way, one can apply the knowledge of solid-state chemistry, materials science and non-ambient conditions to obtain solid forms with optimized properties. These conditions include, among others, different types of mechanical and ultrasonic treatment, hydrostatic compression, high-temperature or cryogenic spray-drying, and crystallization from supercritical solvents. Solid-state reactions (e.g. dehydration or clathrate decomposition) can be efficient in accessing metastable polymorphs or in uniformly micronizing the sample. To achieve control over drug forms and the processes used for their robust manufacturing, one needs to account for both the thermodynamic and kinetic aspects of their transformations.

The review contains over 400 references and provides a comprehensive guide through the vast ocean of publications in this field. This work is based on the personal experience of the author over several decades of active research. ###

For more information visit: http://benthamscience.com/journals/current-pharmaceutical-design/volume/22/issue/32/page/4981/

Elena V Boldyreva

Institute of Solid State Chemistry and Mechanochemistry, Siberian Branch of Russian Academy of Sciences, ul. Kutateladze, 18, Novosibirsk 630128 Russia

 

SMI EVENT – 6th annual Pharmaceutical Microbiology Conference!

SMi proudly presents the return of the 6th annual Pharmaceutical Microbiology conference to London from 18th January – 19th January 2017.

200x200

SMi’s 6th annual Pharmaceutical Microbiology conference will address the complex challenge that the field is facing such as endotoxin testing, best practices in cleaning & disinfection and contamination control case studies.

The bacterial culture media segment accounted for the largest share of the global microbiology culture market in 2014. This segment is likely to continue its increased share until 2023 due to an expected rise in application in food microbiology, pharmaceutical microbiology, and disease research.

The comprehensive agenda will include presentations from both regulatory and industry experts sharing recent case studies and developing trends in the field of pharmaceutical microbiology.

Visit www.pharma-microbiology.com/benth for more information.

First Impact Factor for : Endocrine, Metabolic & Immune Disorders – Drug Targets

News release date: June 23, 2016

Dubai, UAE, June 23, 2016:  Endocrine, Metabolic & Immune Disorders – Drug Targets  has obtained its first Impact Factor 1.987. The Impact Factor ranking has been awarded by Journal Citation Reports®, which are annually published by the Institute of Scientific Information, a division of Thomson Reuters. Its purpose is to offer a systematic means to critically evaluate the world’s leading journals, with quantifiable, statistical information based on citation data.

Endocrine, Metabolic & Immune Disorders – Drug Targets publishes timely reviews of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders.

For more information, please visit http://benthamscience.com/journals/endocrine-metabolic-and-immune-disorders-drug-targets/

Bentham Press Release!

Emerging Sources Citation Index (ESCI) indexes Current Drug Safety

News release date: June 22, 2016

Dubai, UAE, June 22, 2016: Bentham Science journal Current Drug Safety has been accepted for inclusion in Emerging Sources Citation Index (ESCI) and will appear in WoS by August 2016.

Current Drug Safety publishes frontier articles on all the latest advances on drug safety. The journal aims to publish the highest quality research articles, reviews and case reports in the field. Topics covered include: adverse effects of individual drugs and drug classes, management of adverse effects, pharmacovigilance and pharmacoepidemiology of new and existing drugs, post-marketing surveillance. The journal is essential reading for all researchers and clinicians involved in drug safety. For more information about the journal, visit here

As a new index in the Web of Science™ Core Collection, Emerging Sources Citation Index (ESCI) expands the citation universe and reflects the growing global body of science and scholarly activity. ESCI complements the highly selective indexes by providing earlier visibility for sources under evaluation as part of SCIE, SSCI, and AHCI’s rigorous journal selection process. Inclusion in ESCI provides greater discoverability which leads to measurable citations and more transparency in the selection process.

For further information on Emerging Sources Citation Index (ESCI), please visit: http://wokinfo.com/products_tools/multidisciplinary/esci/

Press Release: Bentham Science Journals – Impact Factors 2015

News release date: June 18, 2016

Dubai, UAE, June 18, 2016: According to the recently released Journal Citation Reports® 2015, 39 Bentham Science Journals have received Impact Factors. Current Neuropharmacology has the highest impact factor from all Bentham Science Journals. These positive results reflect the overall high quality of research published by Bentham Science.

Following are the top 10 high impact factor journals published by Bentham Science:

  1. Current Neuropharmacology
    Impact Factor: 3.753
  2. Current Cancer Drug Targets
    Impact Factor: 3.707
  3. Current Drug Targets
    Impact Factor: 3.029
  4. Current Gene Therapy
    Impact Factor: 2.738
  5. Anti-Cancer Agents in Medicinal Chemistry
    Impact Factor: 2.722
  6. Current Stem Cell Research and Therapy
    Impact Factor: 2.645
  7. Current Genomics
    Impact Factor: 2.43
  8. Endocrine, Metabolic & Immune Disorders – Drug Targets
    Impact Factor: 1.987
  9. Medicinal-chemistry
    Impact Factor: 1.458
  10. Mini Reviews in Organic Chemistry
    Impact Factor: 1.394

Journal Citation Reports (JCR) are annually published by the Institute of Scientific Information, a division of Thomson Reuters. Its purpose is to offer a systematic means to critically evaluate the world’s leading journals, with quantifiable, statistical information based on citation data. Bentham Science publishes over 100 print & online scholarly subscription journals; website at http://benthamscience.com/

Free trials of Bentham Journals are active in the following universities & libraries

Wuhan University, China

Wuhan University (WHU) is a comprehensive and key national university directly under the administration of the Ministry of Education. It is also one of the “211 Project” and “985 Project”universities with full support in the construction and development from the central and local government of China.

The history of Wuhan University can be traced back to Ziqiang Institute, which was founded in 1893 by Zhang Zhidong, the then governor of Hubei Province and Hunan Province in the late Qing Dynasty. In the process of development and evolution, the institute changed its name several times before it was finally named Wuhan National University in 1928.

Zhejiang Chinese Medical University, China

Zhejiang Chinese Medical University is located near the south bank of Qianjiang River, in the city of Hangzhou, a world-famous tourist resort known for its beautiful scenery and rich cultural heritage.

In 2001 and 2008, it was awarded “Excellence” on undergraduate education by the Ministry of Education. Two years later, it took the lead among provincial universities in establishing the TCM post-doctor station, and in the same year, the former Zhejiang Jiangong Hospital became its second affiliated hospital. In 2009, the university was authorized to grant doctoral degree in Clinical Medicine and He Ren, the former President of ZCMU, was honored the title of “Master of Chinese Medicine” by the Chinese government.

The university shares 16 SATCM key Specialty and Tertiary Disease Centers, and also 31 provincial key Specialty and Tertiary Disease Centers.

Beijing University of Technology, China

Beijing University of Technology (BJUT) is located at No.100 Pingleyuan, Chaoyang District. The main campus of BJUT covers an area of over 63.97 hectares; in addition there are other 3separate campuses.

Beijing University of Technology was founded in 1960. It is a key university under the administration of the Beijing municipal government, offering multidisciplinary programs in such fields as science, engineering, economics, management, liberal arts and etc. In 1981, BJUT was among the first batch of universities to offer master’s degree programs authorized by Ministry of Education of the People’s Republic of China and in 1985 BJUT was further authorized to offer doctorate degree programs as well. In December 1996 BJUT was finally included in “Project 211”, joining the rank of 100 top universities in the 21st century.


free-trial2

Free Online Trial Request form
http://bit.ly/1BeXpmZ

Email for further assistance:
marketing@benthamscience.org

Bentham Science Publishers collaborates with Kudos!

Bentham Science Publishers is now on Kudos to cater and reach to bigger audiences for the benefit of its authors.

The research articles are available on Kudos to be claimed by the respective authors, hence inviting authors to join Kudos that will help in disseminating their research.

Watch this informative video to learn more!

%d bloggers like this: